Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mack

Showing results (231-240 of 444) with videos related to

Pageof 45
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2016
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics AssayPrimo N Lara, James Moon, Paul J Hesketh, et al.
Global Change Biology|June 13, 2020
Wildfire combustion and carbon stocks in the southern Canadian boreal forest: Implications for a warming worldCatherine M Dieleman, Brendan M Rogers, Stefano Potter, et al.
European Journal of Nutrition|July 6, 2018
Metabolite profiles evaluated, according to sex, do not predict resting energy expenditure and lean body mass in healthy non-obese subjectsM Armbruster, M Rist, S Seifert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancerJeffrey W Allen, James Moon, Mary Redman, et al.
Cancer Treatment and Research Communications|July 25, 2017
Phase II Study of Dovitinib in Patients Progressing on Anti-Vascular Endothelial Growth Factor TherapyThomas J Semrad, Edward J Kim, Michael S Tanaka, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trialRandeep Sangha, Angela M Davies, Primo N Lara, et al.
Investigational New Drugs|September 10, 2013
Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancerCheryl Ho, Angela M Davies, Randeep S Sangha, et al.
Microbiologyopen|July 31, 2013
Analysis of periplasmic sensor domains from Anaeromyxobacter dehalogenans 2CP-C: structure of one sensor domain from a histidine kinase and another from a chemotaxis proteinP Raj Pokkuluri, Jeff Dwulit-Smith, Norma E Duke, et al.
Ecological Applications : a Publication of the Ecological Society of America|June 6, 2024
Factors limiting the potential range expansion of lodgepole pine in Interior AlaskaXanthe J Walker, Sarah Hart, Winslow D Hansen, et al.
Clinical Lung Cancer|February 24, 2015
A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533Antoinette J Wozniak, James Moon, Charles R Thomas, et al.
Pageof 45

Showing results (231-240 of 444) with videos related to

Sort By:
Pageof 45
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2016
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics AssayPrimo N Lara, James Moon, Paul J Hesketh, et al.
Global Change Biology|June 13, 2020
Wildfire combustion and carbon stocks in the southern Canadian boreal forest: Implications for a warming worldCatherine M Dieleman, Brendan M Rogers, Stefano Potter, et al.
European Journal of Nutrition|July 6, 2018
Metabolite profiles evaluated, according to sex, do not predict resting energy expenditure and lean body mass in healthy non-obese subjectsM Armbruster, M Rist, S Seifert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancerJeffrey W Allen, James Moon, Mary Redman, et al.
Cancer Treatment and Research Communications|July 25, 2017
Phase II Study of Dovitinib in Patients Progressing on Anti-Vascular Endothelial Growth Factor TherapyThomas J Semrad, Edward J Kim, Michael S Tanaka, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trialRandeep Sangha, Angela M Davies, Primo N Lara, et al.
Investigational New Drugs|September 10, 2013
Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancerCheryl Ho, Angela M Davies, Randeep S Sangha, et al.
Microbiologyopen|July 31, 2013
Analysis of periplasmic sensor domains from Anaeromyxobacter dehalogenans 2CP-C: structure of one sensor domain from a histidine kinase and another from a chemotaxis proteinP Raj Pokkuluri, Jeff Dwulit-Smith, Norma E Duke, et al.
Ecological Applications : a Publication of the Ecological Society of America|June 6, 2024
Factors limiting the potential range expansion of lodgepole pine in Interior AlaskaXanthe J Walker, Sarah Hart, Winslow D Hansen, et al.
Clinical Lung Cancer|February 24, 2015
A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533Antoinette J Wozniak, James Moon, Charles R Thomas, et al.
Pageof 45